Sep
14

Three things you should check out

First, David DePaolo’s post on the industry’s unfailing ability to believe it can keep doing the same things yet expect better results. David notes:
“A proposed rate filing in [Tennessee] would increase rates by 6.3% is causing regulators to take a look at the medical reimbursement schedule and proposing a reduction in the fee schedule. The same old arguments are at hand in both (or more?) sides of the debate – fees need to be cut because they are too expensive vs. access to care if physicians aren’t adequately compensated.
Stop the madness!! This is the same set of arguments that go nowhere each and every time the issue is raised. And each and every time the issue comes up, adjustments are made to a fee schedule, then everyone goes back to business as usual with cost shifting, procedure manipulation, bill review and utilization review shenanigans and in a few years we again have another crisis.” [emphasis added]
Isn’t that the truth.
Second, Jennifer Wolf-Horesjh (incoming Exec Dir of IAIABC) reminded me that IAIABC hosted an excellent webinar earlier this summer offering a comprehensive look into the opioids issue including recommendations for regulators seeking ways to address the problem. You can download or listen to a recording of the webinar; IAIABC’s making it available at no charge for members and non-members alike.
IAIABC is really focusing on this issue, and I applaud them for doing so.
Third, yesterday’s WorkCompCentral webinar on Prescription Drug Abuse in Workers Comp (your’s truly as presenter) is available for listening at your convenience. As the webinar was over-subscribed, those who werent’ able to ‘attend’ can watch and listen to the replay (no charge). details and a link coming…


Sep
13

NCCI released its 2011 pharmacy study yesterday, and there’s not much in the way of good news. Here are a few of the major take-aways from the research, which used 2009 data.
per-claim drug costs grew by 12% in 2009.
Pharmacy accounts for 19% of work comp medical expense, the highest percentage since NCCI started studying the issue.
OxyContin is now the number one drug. Yippee.
Utilization is the main cost driver, and physician dispensing closely follows. Physician dispensed drugs accounted for 28% of spend in 2009, up a full five points from the previous year.
Let’s take a quick look into a few of the other findings.
The older the claim, the more the drug spend. For claims more than 11 years old, drugs account for more than 40% of costs; for drugs 1 to 2 years old, drugs are a mere 3% of spend.
Drug costs for claims 4 to 9 years old are ” distinctly higher than in previous service years. Subsequent exhibits suggest that increases in physician dispensing might be contributing to this growth.” [emphasis added]
Physician dispensing accounts for fully half of all drug costs in Florida; about 44% in Georgia, 35% in Maryland, and about 32% in PA. Bad as that is, the big problem is that physician dispensing rose dramatically in almost every state. (Note that Hawaii’s decrease from 2008 – 2009 was a temporary situation, as all reports indicate physician dispensing has increased rapidly over the last two years.)
There’s a lot more to the study, and we’ll be digging deep into the research over the next couple days. For now, here’s what this means to you.
It is NOT ABOUT PRICE. Utilization is the main driver of work comp pharmacy costs.
Physician dispensing is the single biggest problem in work comp pharmacy. It’s beyond crisis stage.
With OxyContin the number one drug, we can expect claim durations to increase – people on high-power opioids are NOT going back to work.
And a big “well done” to NCCI’s Barry Lipton, Chris Laws, Linda Li, and their unnamed research associates for what is their best work on drugs to date.


Sep
12

How comparative effectiveness should work.

Merrill Goozner’s piece on the FDA’s decision to pull a stent from the market after it was shown “2 1/2 times (14.7%) more people either died or had a repeat stroke after receiving the stent than those who received drugs and counseling (5.8%).” shows how science can – and should – be brought to what is all-too-often the “art” of medicine.
The stent was approved based on a rather limited study by manufacturer Stryker, but fortunately only approved for use if it that use was as part of an evaluative study.
That study was stopped early due to the higher death/repeat stroke rate; unfortunately it appears that use of the stent may have played a role in patients dying and/or having more strokes.
The good news is the stent is, or soon will be, off the market. The bad news – outside of that delivered to the families of those who died possibly as a result of the stent – is that this is actually “news”.
The reason this device was pulled from the market is because it was only approved on a limited basis by the FDA, who could pull that approval relatively easily. For devices and drugs and treatments already approved by, or not subject to approval by, the FDA (or any other regulatory authority) it is much more difficult to get them off the market. And it’s impossible for Medicare to factor effectiveness into payment.
If we are to gain any measure of control over health care costs, we have to start by paying for performance – not just for docs, but for drugs and devices as well. One wouldn’t think that would require the proverbial “Act of Congress’, but it does.
Perhaps the Super-Committee can decide that one way to attack the deficit is to stop paying for unproven treatments, or at least stop paying so much if the treatments aren’t proven to be effective. Can you imagine what that would do to health care? Actually paying for good stuff rather than paying for anything that gets prescribed for/inserted into/done to a patient?


Sep
10

Regulating work comp…

There is one industry that’s more highly regulated than workers comp – nuclear power.
Other than that, and perhaps commercial airline travel, comp is it. Sure, there’s varying degrees of regulatory control, there’s no getting around the fact that most of what happens in and around work comp is driven by regulations. Often, the regulators are tasked with developing rules and regs based on legislation written by (speaking generously) non-expert elected officials. This isn’t to slam state legislators, but rather to recognize that they are part-time elected officials working with very limited resources and support who have to develop and vote on legislation that in many cases is far outside their area of expertise.
The legislation on which regulators base their rules may be pretty broad, thereby leaving the rule-writers with a lot of discretion – and potentially opening the door to legal challenge by stakeholders disagreeing with the regulators’ interpretation of the law.
It may also be written with a lot of detail, thereby challenging regulators to develop regulations that will actually work in the real world (which is a different world than the one in which some non-expert legislators operate).
Which puts a LOT of responsibilty on – and vests a lot of authority in – regulators. In my experience, most of the folks tasked with developing and implementing work comp regulations are pretty reasonable, open-minded, and highly knowledgeable. They aren’t looking to antagonize or frustrate stakeholders, but rather take the legislation and laws they are handed and figure out how they can develop regs that a) abide by the intent of the lawmakers and b) can actually work to enhance the quality of care and reduce costs.
That’s harder than it may seem.
For example, let’s say a state legislature passes a law designed to reduce workers comp expenses, and that law includes a requirement to reduce medical expenses. This type of legislation may well include a cut in the fee schedule, as that looks to be a pretty straightforward way to reduce medical costs – if you cut the price, then you cut the cost.
However, there are several studies that show there’s a tenuous connection at best between low fee schedules and low medical costs, and quite a few people think reducing reimbursement can actually lead to higher costs due to increased utilization and decreased quality of care (this is a complex issue that can’t be adequately addressed in this post). Regulators, who understand this issue, are faced with a no-win situation – they’re tasked with figuring out how to reduce costs but are forced to use a tool that may well have the opposite effect.
Sort of a damned if they do situation…
There’s an enlightening piece in Risk and Insurance about the interaction between regulators and stakeholders that provides good perspective on this issue.


Sep
8

Medicare – quick factoids

There’s going to be a LOT coming out in the next two months about Medicare, so it may help to know a few things about the program to help put it in context.
– We spent over a half-trillion dollars on Medicare in 2010.
– That’s fifteen percent of total Federal expenditures.
– 48 million people were covered in 2010.
– The health reform bill (aka the PPACA of 2010) is credited with reducing Medicare costs by by $424 billion (net ten-year savings) over the next ten years, certainly a step in the right direction.
– That equates to a 3.5% annual growth rate – almost two full points lower than projected per-capita growth in private health insurance spend.
– Despite those reductions, costs will get to within whispering distance of a trillion dollars in ten years.
– All those reductions don’t come without pain. In fact, Medicare’s Office of the Actuary projects Medicare reimbursement rates will be lower than Medicaid’s…a result that may well lead to providers abandoning the system.
– Some of that pain may start January 1st, when physician reimbursement is slated for a 29.4% across-the-board cut.
So. We have – on the one hand, huge costs that are getting bigger despite aggressive efforts to slash growth. And on the other, we have consequences that look pretty daunting – dramatically reduced reimbursement that will almost certainly lead to access problems for beneficiaries.
What does this mean for you?
There are no simple, easy, painless answers. Every time you hear someone talking about one aspect of the issue (physician payment, impact on the deficit, access problems, reductions in payments to Medicare Advantage plans) remember there’s another side to the issue, another perspective that almost certainly can make a well-founded and reasonable counter-argument.
he super committee and medicare – KFF report on implications


Sep
7

Work comp conference – Two months and counting

The biggest national work comp get-together is – hard to believe it – coming up in two months. While I’m somewhat conflicted about the location (I like Chicago a LOT more than Vegas…) the event is always well worth the trip.
This year I’ll be on the podium helping to kick off the conference – along with Davidson Pattiz of Zenith and Dave North of Sedgwick, two gentlemen who don’t always agree with everything I say or write (shocking, I know). The idea is I get to pontificate upon talk about what will affect workers comp tomorrow, the condition of the industry today, and some of the problems I see, and then Davidson and Dave get to tell you where and how I’m wrong.
This will be fun.
Lest you fall for the pre-conference hype, the three of us have specifically agreed to foreswear violence, conduct ourselves with professionalism and respect each other’s opinions.
Except if we really disagree.


Sep
6

Work comp drugs – What works in Washington…

There has been a lot of discussion about the WCRI report on Washington State’s workers’ compensation pharmacy costs. Unfortunately a good bit of the discussion has been rather simplistic, citing some of the findings without placing those findings in the correct context.
Washington’s workers compensation environment is unique. As one of the very few (that would be three) states with a monopolistic workers comp fund, the state’s regulatory reach and control over all aspects of workers comp is broad and deep. Simply put, Washington state can dictate terms to all participants including employers, providers, pharmacies, and other stakeholders, terms that the stakeholders must comply with. Moreover, providers and pharmacies in Washington do not need to concern themselves with eligibility issues, questions about coverage or payment or fiduciary responsibility. Compared to other states, this is a markedly different operating environment for providers and pharmacies.
News stories following the study’s release of the report stressed some of Washington’s cost-containment tactics, implying that other states could replicate these tactics and thereby enjoy similar benefits. However, neither WCRI’s news release or subsequent media stories stressed that Washington is a monopolistic state with a single payer system without the eligibility issues existing in states with multiple payers (carriers, third-party administrators and self-administered employers).
For pharmacies participating in the workers comp system in Washington, the single-payer system eliminates confusion and work associated with identifying their customer’s workers comp payer. The defined formulary and coverage policies ensure pharmacies’ ‘risk’ associated with dispensing medications to injured workers is quite low as pharmacies are all but assured that their bills will be paid. Moreover, pharmacies are tied electronically to L&I, further reducing their administrative expense and workload.
This environment could not be more different than the one in non-monopolistic states, where determining coverage is a complex and tedious task often requiring multiple phone calls and letters; ascertaining formulary compliance is difficult and uncertain; and pharmacies must assume substantial financial risk for medications dispensed to injured workers.
Given the differences between Washington and almost all other states, it is abundantly clear that what works in Washington will not work in non-monopolistic states. While simplistic solutions are often attractive, they are also often counter-productive.


Sep
2

Medicare Fraud – what’s really happening

Everyone seems convinced there’s a ton of fraud in Medicare. And they may be right. What there wasn’t, for far too long, was much emphasis on finding and prosecuting the criminals stealing from taxpayers by defrauding Medicare.
Well, looks like that’s changed. This ‘story’ was first broken a week ago by Merrill Goozner, one of the more insightful observers of the health care scene. Here’s a piece from an OIG release quoted in Merrill’s post:
“Since their inception in March 2007, [CMS anti-fraud] Strike Force operations in nine locations have charged more than 1,000 individuals who collectively have falsely billed the Medicare program for more than $2.3 billion.”
CMS’ anti-fraud efforts are finally getting some press. For instance, prosecutions are up 85% over last year. Compared to five years ago, there’s been a 71% increase. It takes quite a bit of time to develop a prosecute a health care fraud case, as laws and regulations are quite complex and often confusingly contradictory; following the paper trail is difficult at best; and company ownership and fiduciary responsibility usually hard to identify and even more difficult to prove; thus it’s no surprise it’s taken a couple years for the Obama Administration to start to produce major results.
According to the piece in FierceHealthcare;
“The government prosecuted 903 cases of healthcare fraud, up 24 percent from last year, reports USA Today. The increased numbers come from more investigations under the close attention of the Federal Bureau of Investigation (FBI) and the Medicare Fraud Task Force, as well as the participation of whistleblowers. The FBI recently changed their focus to target criminal enterprises, including hospitals. In 2010, the government paid out $300 million to whistleblowers.”
Health care geeks may recall that the PPACA was supposed to deliver $4.9 billion in savings over ten years due to better controls over fraud and abuse. Looks like that was a ‘gimme’, as the GAO reported savings in 2010 alone were $4 billion.
These prosecutions often netted criminals defrauding commercial insurers as well as we taxpayers – one case in Puerto Rico nailed hundreds of crooks who stole $7 million from AFLAC.
Another CMS-led effort earlier this year resulted in indictments of 111 individuals for allegedly defrauding Medicare of $225 million.
That’s all to the good – perhaps as much for the ‘Sentinel Effect’ as for catching these thieves. Others who may be tempted to steal from the Feds or commercial payers may be a bit de-motivated when they hear about prison terms and hefty fines levied against others with the same idea.
There’s no question Medicare is a prime target for crooks large and small. After all, it’s a program that pays out billions each year, so there’s bound to be fraud. Commercial health plans, workers comp insurers, and other payers are certainly vulnerable and often victimized as well. Here’s hoping the recent press attention leads to even more attention on fraud, and more convictions as well.
What does this mean for you?
Are your SIU people tied into the CMS Strike Forces, sharing information and collaborating on investigations?


Sep
1

The Super-Committee; 83 days and counting

In MCM’s ongoing effort to keep our loyal readers apprised of things that will affect their businesses, it’s time to remind one and all that the Super-Committee’s budget cuts are due in less than three months.
Yep, in 83 days or so, six Republicans and six Democrats are supposed to come up with (at least) $1.2 trillion in cuts. If they don’t, automatic cuts will be triggered beginning in 2013, including a two percent cut in Medicare (and that’s assuming the pending SGR cuts hit on January 1…)
Couple of key points that bear mentioning;
1. the $1.2 trillion is spread over the next decade. Cuts could be back-loaded to minimize political fallout – and probably will be (if the group reaches agreement)
2. the automatic cuts take effect January 2013 – a lifetime away in political terms. Congress could do something else to prevent some of the automatic, or Group of Twelve cuts from occurring, modify the cuts, or pass a “fooled you, we were just kidding” law.
Back to the committee. As we’ve noted, it’s difficult to see how they can hit their target unless health care is addressed.
There’s no consensus on whether the twelve will manage to reach consensus or not. With an election year coming up, it’s hard to see how the GOP’s folks will agree to any kind of revenue increases, while Dems have been quite public about their intent to prevent cuts to entitlements. And if they don’t, as Steve Davis noted in an online piece on AISHealth, “Across-the-board reductions in Medicare payment could translate to more cost shifting by providers, which could lead to higher premiums charged by commercial plans and/or increased cost shifting onto employee-based coverage”.
That said, there’s some hope that statesmen-like traits will somehow take hold in the group and we’ll actually see them arrive at a grand bargain. If such a happy event occurs, expect to see:
– subsidies for Medicare Advantage programs cut
– a potential increase in eligibility age for Medicare recipients
– decrease in hospital reimbursement under Medicare
– means testing premiums for Medicare

You’ll note these are all focused on Medicare. Medicaid is unlikely to be cut dramatically – but then again, we just don’t know.
This all supposes the SGR cuts to physician reimbursement actually take effect on January 1 2012 – which is about as likely as our house getting power this week (no chance at all). If it doesn’t, there’s another $300 million or so in cuts that will have to be made.
What does this mean for you?
Watch carefully what happens with the Super Committee…It WILL affect you.


Aug
30

Goodnight Irene

We dodged a bomb.
Here in New England, it always seems the greater the media coverage around weather events, the less dramatic the impact when the actual events hit. Fortunately Irene was no exception. That’s not to minimize the impact of Irene and especially the devastation in Vermont and upstate New York; reports indicate the damage far inland far exceeds what those of us on the coast experienced. While we are without power – and likely will be for another week or so – that’s a minor inconvenience in comparison.
The silver lining of Irene’s dark cloud is the impact on insurance markets. While irene’s bill won’t be large enough to turn the market harder, it’s likely to have more of an additive effect, coming as it did on top of the tornadoes, tsunami, and flooding earlier in the year. The sum of all these events will certainly help to firm up the P&C market and not just in property lines. Insurers are looking for any reason to increase rates and this latest event may well push a few more to tighten underwriting and raise premiums.
We would do well to remember we are nowhere near the end of hurricane season; Irene has relatives that may come calling this fall and they may be nastier still.